Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
06/2004
06/30/2004EP1433781A1 Pyrrolidine carboxylic acid derivatives
06/30/2004EP1433479A1 Appetite-stimulating agents and remedies for anorexia
06/30/2004EP1432706A2 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors
06/30/2004EP1432701A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
06/30/2004EP1432698A2 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
06/30/2004EP1432696A1 Chroman derivatives as 5-hydroxytryptamine-6 ligands
06/30/2004EP1432694A1 Stereospecific process for the synthesis of 2-yl chroman derivatives
06/30/2004EP1432693A2 Mch receptor antagonists
06/30/2004EP1432691A1 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
06/30/2004EP1432690A2 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
06/30/2004EP1432420A2 Benzimidazolidinone derivatives as muscarinic agents
06/30/2004EP1432416A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
06/30/2004EP1432415A1 Substituted 2,5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases
06/30/2004EP1432313A1 N-thio-nicotinamide derivatives and related compounds for use as pesticides
06/30/2004EP1070056B1 Phthalazinone pde iii/iv inhibitors
06/30/2004EP1037880B1 Retinoic acid mimetic anilides
06/30/2004EP1009743B1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
06/30/2004CN1509286A Metalloproteinase inhibitors
06/30/2004CN1509282A 4-(phenyl-piperdin-4-ylidene-methyl)benzamide derivatives and theive use for treating pain, anxiety or gastrointestinal disorders
06/30/2004CN1509278A N-phenyl-arylsulfonamide compound, drug comprising the compound as active ingredient, intermediate for the compound
06/30/2004CN1509276A Metalloproteinase inhibitors
06/30/2004CN1509275A Metalloproteinase inhibitors
06/30/2004CN1509274A Metallo proteinase inhibitors
06/30/2004CN1509273A Metalloproteinase inhibitors
06/30/2004CN1509272A Metalloproteinase inhibitors
06/30/2004CN1509271A 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for treatment of pain anxiety or gastrointestinal disorders
06/30/2004CN1155597C Benzodioxan, benzofuran or benzopyranl derivatives having fundic relaxation properties
06/30/2004CN1155596C New phenylpiperazines
06/30/2004CN1155590C Chromone compounds with antineoplastic activity and its open-loop products and preparing process
06/29/2004US6756393 Amides and ureas n-substituted with piperidine or nortropane; serotonin inverse agonists or antagonists; antipsychotic
06/29/2004US6756388 Having piperidinyl and phenolic functionality; bone loss; breast or prostate cancer
06/29/2004US6756387 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
06/29/2004US6756385 Imidazole derivatives
06/29/2004US6756374 Diaminothiazoles having antiproliferative activity
06/29/2004US6756372 For therapy of autoimmune diseases, alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, crohn's disease, ulcerative colitis, multiple sclerosis, guillain-barre syndrome, psoriasis
06/29/2004US6756371 Morpholino or thiomorpholino derivatives; respiratory system disorders
06/29/2004US6756370 Piperidine alcohols
06/29/2004US6756367 Useful in the treatment of any state with increased endogenous level of corticotropin releasing hormone(crf) or hpa (hypothalamic pituitary axis) is disregulated or diseases induced by crf, including inflammatory disorders, anxiety etc
06/29/2004CA2204451C Method of selecting a salt for making an inclusion complex
06/29/2004CA2171827C Use of thiazolidinediones to prevent or delay onset of niddm
06/24/2004WO2004052995A1 Process for the production of meso-substituted cyanine dyes
06/24/2004WO2004052887A2 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
06/24/2004WO2004052886A1 Indol derivatives and their use as 5-ht ligands
06/24/2004WO2004052884A1 Anthranilic acid amide derivatives and their pharmaceutical use
06/24/2004WO2004052880A1 Pyridine derivatives as jnk inhibitors and their use
06/24/2004WO2004052869A1 5-substituted-pyrazine or pyridine glucokinase activators
06/24/2004WO2004052864A1 Pyrazole and imidazole compounds and uses thereof
06/24/2004WO2004052861A1 Hydroxyalkylated cyclic diamine compound
06/24/2004WO2004052854A2 Aryl, aryloxy, and alkyloxy substituted 1h-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
06/24/2004WO2004052851A1 Pyrrolydin-2-one derivatives as inhibitors of thrombin and factor xa
06/24/2004WO2004052373A1 Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k
06/24/2004WO2004052366A1 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists
06/24/2004WO2004052313A2 Anti-infectives
06/24/2004WO2004052312A2 Anti-infectives
06/24/2004WO2004012684A3 M3muscarinic acetylcholine receptor antagonists
06/24/2004WO2004011425A3 Indole, azaindole and related heterocyclic ureido and thioureido piperazine derivatives
06/24/2004WO2003060078A3 Heterocyclic modulators of nuclear receptors
06/24/2004WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/24/2004US20040122238 for color photography
06/24/2004US20040122237 Substituted benzazoles and methods of their use as inhibitors of Raf kinase
06/24/2004US20040122235 such as N-(2-Phenoxyphenyl)-N'-(thiazol-2-yl)urea; for treating diseases in which increasing glucokinase activity is beneficial (diabetes)
06/24/2004US20040122234 Growth Hormone secretagogues
06/24/2004US20040122227 Cyclic guanidine derivatives and their use as pesticides
06/24/2004US20040122219 Azo compound and process of producing the same, and novel compound and process of producing azo compounds using the same
06/24/2004US20040122074 1-[5-(4-chloro-phenyl)-1-(2-chloro-phenyl)-4-methyl-1H-pyrazol-3-yl]-2-piperidin-1-yl-ethanone,e.g. as antagonist or inverse agonists; nicotine partial agonist; an opioid antagonist; a dopaminergic agent; an attention deficit disorder agent
06/24/2004US20040122063 Ethylenediamine derivatives
06/24/2004US20040122053 2-(substituted-phenyl)amino-imidazoline derivatives
06/24/2004US20040122049 heterocyclic derivatives containing N-substituted piperidine ring and an amide or urea group; useful for treating rheumatic arthritis
06/24/2004US20040122031 Thiazolidinedione and pharmaceutical composition comprising the same
06/24/2004US20040122016 Compositions useful as inhibitors of rock and other protein kinases
06/24/2004US20040122005 Isoxazoline derivatives as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme
06/24/2004US20040121996 Benzoxazin-3-ones and derivatives thereof as therapeutic agents
06/24/2004US20040121975 Hepatitis C virus assays
06/24/2004US20040121964 For prophylaxis and therapy of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atherosclerosis, and various immunomodulatory diseases
06/24/2004DE69233189T2 Heteroarylpiperidine-pyrrolidine und piperazine und ihre anwendung als antipsychotisches und analgetisches mittel Heteroarylpiperidines-pyrrolidine and piperazine and its application as an antipsychotic and analgesic medium
06/24/2004DE10256982A1 New epithilone derivatives are useful for the treatment of diseases associated with proliferative diseases e.g. tumor diseases, inflammatory diseases and neurodegenerative diseases
06/24/2004CA2509191A1 Aryl, aryloxy, and alkyloxy substituted 1h-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
06/24/2004CA2508608A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
06/24/2004CA2508601A1 Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k
06/24/2004CA2506164A1 Anthranilic acid amide derivatives and their pharmaceutical use
06/24/2004CA2505887A1 Pyrazole and imidazole compounds and uses thereof
06/23/2004EP1431285A1 Reverse hydroxamic acid derivatives
06/23/2004EP1430120A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
06/23/2004EP1430051A1 N-(4-(4-methylthiazol-5-yl)pyrimidin-2-yl)-n-phenylamines as antiproliferative compounds
06/23/2004EP1430050A1 Piperidine derivatives and their use as modulators of chemokine (especially ccr3) activity
06/23/2004EP1430048A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
06/23/2004EP1430043A1 Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists
06/23/2004EP1430042A2 Bicyclic heterocycles as rxr ligands
06/23/2004EP1430040A1 Benzothiazepine derivatives
06/23/2004EP1430039A2 Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis
06/23/2004EP1430032A2 Substituted amides for the treatment of neurological disorders
06/23/2004EP1430029A1 N-type calcium channel antagonists for the treatment of pain
06/23/2004EP1429765A2 Inhibitors of histone deacetylase
06/23/2004EP1429764A1 Compositions and methods for the treatment of cancer
06/23/2004EP1429763A2 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER
06/23/2004EP1252157B1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
06/23/2004EP1251848B1 Gyrase inhibitors and uses thereof
06/23/2004EP1066283B1 Substituted indolealkanoic acids
06/23/2004EP1036075B1 Substituted thiazolidinedione and oxazolidinedione having antidiabetic, hypolipidemia and antihypertensive properties
06/23/2004CN1507446A Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors